IRIS
DE VITA, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.524
AS - Asia 13.098
EU - Europa 8.783
SA - Sud America 2.543
AF - Africa 288
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 18
AN - Antartide 2
Totale 53.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.067
SG - Singapore 6.171
CN - Cina 2.681
UA - Ucraina 2.503
BR - Brasile 2.047
HK - Hong Kong 1.472
DE - Germania 1.337
IT - Italia 1.102
VN - Vietnam 1.033
FI - Finlandia 802
RU - Federazione Russa 625
FR - Francia 574
SE - Svezia 523
IE - Irlanda 479
GB - Regno Unito 377
IN - India 345
TR - Turchia 265
KR - Corea 261
CA - Canada 260
AR - Argentina 174
BD - Bangladesh 165
MX - Messico 111
EC - Ecuador 98
IQ - Iraq 95
ZA - Sudafrica 83
JP - Giappone 80
ID - Indonesia 79
NL - Olanda 73
AT - Austria 68
PL - Polonia 68
PK - Pakistan 61
CO - Colombia 52
MA - Marocco 51
IR - Iran 46
UZ - Uzbekistan 45
ES - Italia 44
CL - Cile 41
PY - Paraguay 40
SA - Arabia Saudita 40
PH - Filippine 39
VE - Venezuela 36
CZ - Repubblica Ceca 35
EG - Egitto 33
BE - Belgio 32
EU - Europa 27
TG - Togo 22
UY - Uruguay 22
TN - Tunisia 20
MY - Malesia 19
PE - Perù 19
AE - Emirati Arabi Uniti 18
JM - Giamaica 18
DO - Repubblica Dominicana 16
IL - Israele 16
LT - Lituania 16
NP - Nepal 16
AZ - Azerbaigian 15
GR - Grecia 15
JO - Giordania 15
KE - Kenya 14
KZ - Kazakistan 14
PT - Portogallo 14
BO - Bolivia 13
CR - Costa Rica 13
LB - Libano 13
AU - Australia 12
CH - Svizzera 12
DZ - Algeria 12
OM - Oman 11
AL - Albania 10
ET - Etiopia 10
RO - Romania 10
TW - Taiwan 10
HR - Croazia 9
KG - Kirghizistan 9
TT - Trinidad e Tobago 9
LK - Sri Lanka 8
PA - Panama 8
PS - Palestinian Territory 8
DK - Danimarca 7
NO - Norvegia 7
TH - Thailandia 7
HN - Honduras 6
HU - Ungheria 6
KW - Kuwait 6
NG - Nigeria 6
RS - Serbia 6
SN - Senegal 6
SY - Repubblica araba siriana 6
AM - Armenia 5
EE - Estonia 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
AO - Angola 4
BY - Bielorussia 4
GA - Gabon 4
GE - Georgia 4
LV - Lettonia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
Totale 53.215
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.780
Ann Arbor 2.593
Singapore 2.492
Fairfield 2.015
Houston 1.990
Jacksonville 1.765
Ashburn 1.741
Chandler 1.522
Hong Kong 1.445
Beijing 1.286
Wilmington 1.003
Dearborn 967
San Jose 831
Seattle 717
Boardman 658
Cambridge 616
Council Bluffs 482
Dublin 474
Lauterbourg 466
Princeton 466
Los Angeles 348
Ho Chi Minh City 344
Udine 305
Hefei 254
Seoul 239
Helsinki 227
Buffalo 222
Hanoi 209
Dallas 205
Munich 199
Izmir 191
San Diego 186
São Paulo 178
The Dalles 154
New York 148
Redondo Beach 135
Ottawa 132
Santa Clara 113
Ogden 104
Des Moines 103
Norwalk 92
Dong Ket 78
Mumbai 74
Orem 72
Nuremberg 66
Nanjing 60
Frankfurt am Main 58
Trieste 58
Belo Horizonte 55
Tokyo 55
Rio de Janeiro 54
Redmond 53
London 52
Guangzhou 50
Milan 46
Warsaw 46
Brooklyn 44
Johannesburg 44
San Mateo 43
Kunming 42
Montreal 42
Phoenix 42
Falls Church 41
Rome 40
Tashkent 39
Atlanta 37
Haiphong 37
Toronto 37
Baghdad 36
Chennai 36
Denver 36
Guayaquil 36
Da Nang 35
Brasília 34
Mexico City 34
Amsterdam 33
Quito 33
Salvador 32
Shanghai 32
Stockholm 32
Curitiba 30
Augusta 29
Brussels 28
Chicago 28
Turku 28
Vienna 28
Brno 26
Düsseldorf 26
Hải Dương 26
Manchester 26
Campinas 25
Lahore 25
Porto Alegre 25
Simi Valley 25
Andover 24
New Delhi 24
Pittsburgh 23
San Francisco 23
Lomé 22
Ribeirão Preto 22
Totale 33.684
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 317
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 201
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 199
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients 192
A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: A nationwide multi-center retrospective observational study 192
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 191
Absence of human parvovirus B19 DNA in myoepithelial sialadenitis of primary Sjögren's syndrome. 188
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 187
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 186
Terapia dell'artrite reumatoide con immunoglobuline per via endovenosa ad alte dosi: esperienza clinica e revisione della letteratura 185
Validation of the classification criteria for cryoglobulinaemic vasculitis. 183
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 183
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 181
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 180
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 179
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 178
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts 176
Efficacy and safety of rituximab in type II mixed cryoglobulinemia. 175
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 175
Efficacy and safety of rituximab in type II mixed cryoglobulinemia 174
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 174
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 173
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 172
Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study 172
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 171
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 170
B-cell lymphomas associated with HCV infection 169
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 169
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 168
Medical data quality assessment: On the development of an automated framework for medical data curation 168
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 167
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 164
Use of teriparatide in osteoporosis due to active rheumatic diseases 163
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 163
EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome. 162
Knuckle pads mimic early psoriatic arthritis 162
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma 161
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 161
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 160
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 159
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 159
Misoprostol-induced urinary incontinence 158
Emerging drugs for primary Sjögren’s syndrome 158
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 157
Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 156
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 156
Plasmocitoma micromolecolare osteosclerotico 155
SALIVARY GLAND ECHOGRAPHY IN PRIMARY AND SECONDARY SJOGREN'S SYNDROME 155
Rituximab for the treatment of type II mixed cryoglobulinemia. 155
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 155
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 154
BLyS and April serum levels in patients with autoimmune thyroid diseases. 154
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. 154
Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue 152
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 152
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 151
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 151
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 151
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 150
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 150
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 150
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 150
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 150
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 149
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 148
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 148
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). 147
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 146
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 146
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 145
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 145
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 144
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. 144
B-lymphocyte stimulator and a proliferation-inducing ligand serum levels in IgA-deficient patients with and without celiac disease 144
BLyS Role in the Diagnosis and Prognosis of Neuroendocrine Tumors: Preliminary Results. 144
Efficacy of selective B cell Blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells 144
Combination therapy with cyclosporin-A plus methotrexate in adult Still’s disease: efficacy and safety. . 143
Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. 143
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 143
B cell driving cytokines in eraly rheumatoid arthritis. Assessment of possibile clonal expansions during treatment with cyclosporin A. Arthritis and Rheumatism 1996; 39 (Suppl.): S26. 142
General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus 142
Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjögren's syndrome 142
The Detection of Anti-adalimumab Antibodies in a Series of Inflammatory Polyarthritis: three ELISA Methods Compared 142
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 142
Dermoscopy in the differential diagnosis between malar rash of systemic lupus erythematosus and erythematotelangiectatic rosacea: an observational study 142
Multifocal ischemic necrosis of bone in scleroderma. 141
B-cell compartment as the selective target for the treatment of immune thrombocytopenias 141
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 141
Combinad therapy with cyclobenzaprina and ipuprofen in primary fibromialgia sindrome 140
Classification of cryoglobulinemic vasculitis 139
Treatment of giant cell arteritis with cyclophosphamide pulses 139
Frequent detection of human herpesvirus 6 DNA in HIV-associated lymphadenopathy. 139
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 139
Subtypes of Epstein-Barr virus in HIV-1-associated and HIV-1-unrelated Hodgkin's disease cases. 139
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 139
Myositis in primary sjögren's syndrome: data from a multicenter cohort 138
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 138
Infection of neoplastic B cells by HCV in low-grade non-Hodgkin’s lymphomas associated with type II mixed cryoglobulinemia. 138
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 138
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 137
Totale 15.944
Salva come PNG Salva come JPEG
Categoria #
all - tutte 203.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 203.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021239 0 0 0 0 0 0 0 0 0 0 0 239
2021/20223.523 89 403 162 380 108 105 156 232 48 532 673 635
2022/20233.839 515 167 69 427 393 1.043 33 287 574 56 114 161
2023/20241.238 179 120 47 26 223 190 51 93 168 67 24 50
2024/20258.740 202 606 300 238 391 413 451 581 931 765 1.402 2.460
2025/202614.488 1.100 1.468 1.293 1.524 2.183 1.273 1.653 553 1.023 1.256 890 272
Totale 54.195